XML 35 R14.htm IDEA: XBRL DOCUMENT v3.25.0.1
Related Party Transactions
 12 Months Ended
Dec. 31, 2024
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions
Related Party Revenues
Total related party diagnostic testing revenues were $1.7 million and $3.2 million for the years ended December 31, 2024 and 2023, respectively. Related party revenues primarily include diagnostic testing revenues from a subsidiary of OPKO and the prices charged represent market rates.
Related Party Expenses
Total related party costs are included within cost of services and related party expenses in the consolidated statements of operations and comprehensive loss as follows:
Year Ended December 31,
20242023
Costs of services$9,228 $4,338 
General and administrative— 435 
Other operating expenses, net3,407 5,266 
Total related party costs$12,635 $10,039 
Expenses recognized pursuant to other service arrangements with ISMMS totaled $4.6 million and $6.8 million for the years ended December 31, 2024 and 2023, respectively. These amounts are included in either cost of services or other operating expenses, net on the consolidated statements of operations and comprehensive loss depending on the particular activity to which the costs relate. Payables due to ISMMS for the other service arrangements were $0.9 million and $1.0 million as of
December 31, 2024 and December 31, 2023, respectively. These amounts are included within due to related parties on the Company’s consolidated balance sheets.
Additionally, the Company incurred $10.5 million and $3.4 million in purchases of diagnostic testing kits and materials and $8.1 million and $1.8 million was recorded in cost of services for the year ended December 31, 2024 and 2023, respectively, from an affiliate of a member of the Board of Directors who has served in the role since July 2021. The prices paid represent market rates. Payables due were $0.7 million and $0.4 million as of December 31, 2024 and 2023.
Legacy GeneDx and OPKO entered into a Transition Services Agreement dated as of April 29, 2022 (the “OPKO TSA”) pursuant to which OPKO had agreed to provide services, at cost, subject to certain limited exceptions, in order to facilitate the transactions contemplated by the Acquisition Merger Agreement, including human resources, information technology support, and finance and accounting. Services in connection with the OPKO TSA were fully completed in October 2023. The Company recognized $1.6 million in costs for the year ended December 31, 2023 related to the agreement.